Panakeia
Next generation multi-omics and biomarker profiling from routine tissue images
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- panakeia.ai
- Total Funding
- $3.8M
- Last Round
- $3.7M SeedOct 2019
About
Panakeia is an AI-powered digital pathology company based in London that provides next-generation multi-omics and biomarker profiling directly from routine H&E-stained tissue images. Its platform, PANProfiler, delivers molecular insights in minutes rather than the days or weeks required by traditional physical laboratory tests, enabling faster and more accurate cancer diagnostics. Panakeia partners with leading institutions including Cancer Research UK, King's College London, Tech Nation, and PathLAKE, and serves both hospital and laboratory clinical settings as well as pharmaceutical research teams.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.